Windlas Biotech Limited (BOM:543329)
India · Delayed Price · Currency is INR 934.00
-1.40 (-0.15%)
At close: Jul 17, 2025
Windlas Biotech Revenue
In the fiscal year ending March 31, 2025, Windlas Biotech had annual revenue of 7.60B INR with 20.43% growth. Windlas Biotech had revenue of 2.08B in the quarter ending March 31, 2025, with 21.23% growth.
Revenue
7.60B
Revenue Growth
+20.43%
P/S Ratio
2.57
Revenue / Employee
n/a
Employees
1,154
Market Cap
19.55B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,646.93B |
| HDFC Bank | 2,728.47B |
| Tata Consultancy Services | 2,561.48B |
| Bharti Airtel | 1,729.85B |
| ICICI Bank | 2,006.54B |
| State Bank of India | 3,429.39B |
| Infosys | 1,647.16B |
| Hindustan Unilever | 631.21B |